Browse by Vaccine Status

This page shows data for Approved Vaccine Status.
Total Entries Retrieved: 145
IDVaccine NameDisease NameDisease ClassificationVirus NameNucleic Acid ContentVaccine TypeVaccine StatusManufacturerYear of ManufacturingManufacturing CountryAgeDosageAdministration RouteAdjuvantTarget StrainDescriptionApproving OrganisationCollaborating OrganisationOther CountriesTrade NamePMIDClinical Trial IDReference LinkAdditional Links
10001 Spikevax COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA RNA based vaccine Approved Moderna Inc. 2020 USA 18 years and above 2 doses 28 days apart Intramuscular NA Spike protein of SARS-CoV-2 virus mRNA based vaccine US FDA NA USA, Canada, UK, Netherlands, Denmark, Germany, Switzerland mRNA-1273, CX-024414, COVID-19 mRNA Vaccine Moderna, TAK-919, Moderna COVID‑19 Vaccine, COVID‑19 Vaccine Moderna, COVID-19 Vaccine Moderna Intramuscular Injection, Elasomeran NA NCT04969250 https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/spikevax-and-moderna-covid-19-vaccine NA
10002 CoronaVac COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Sinovac Biotech Ltd. 2021 China 18 - 59 years 2 doses 28 days apart Intramuscular NA Antigenic strain of H1N1, H3N2, BV and BY NA NA NA NA PiCoVacc, Inactivated SARS-CoV-2 vaccine (Vero cell) NA NCT04801888 https://clinicaltrials.gov/show/NCT04801888 https://cdn.who.int/media/docs/default-source/immunization/sage/2021/april/4_sage29apr2021_sinovac.pdf
10003 Inactivated SARS-CoV-2 vaccine (Vero cell) COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Hubei Provincial Center for Disease Control and Prevention 2020 China NA NA Intramuscular NA NA NA NA NA NA NA NA NA http://www.chictr.org.cn/showproj.aspx?proj=126385 NA
10004 Inactivated SARS-CoV-2 vaccine (Vero cell) COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Shanghai Municipal Center for Disease Control and Prevention 2021 China NA NA Intramuscular NA NA NA NA NA NA NA NA NA http://www.chictr.org.cn/showproj.aspx?proj=126277 NA
10005 KconecaVac COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Shenzhen Kangtai Biological Products Co. Ltd 2021 China 18 years and above 2 doses 28 days apart Intramuscular NA NA NA China FDA NA NA NA NA NCT04852705 https://clinicaltrials.gov/show/NCT04852705 https://www.reuters.com/article/us-health-coronavirus-vaccine-kangtai/kangtai-biologicals-covid-19-vaccine-gets-emergency-use-approval-in-china-idUSKBN2CV1F6
10006 Inactivated SARS-CoV-2 vaccine (Vero cell) COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Shanghai Oriental Hospital 2021 China NA NA Intramuscular NA NA NA NA NA NA NA NA NA http://www.chictr.org.cn/showproj.aspx?proj=122756 NA
10007 Abdala COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Protein subunit Approved Center for Genetic Engineering and Biotechnology 2021 Cuba 19 - 80 years NA Intramuscular Aluminum (aluminium hydroxide) NA NA Cuba Drug Regulator NA Cuba, Venezuela CIGB-66 NA NA https://rpcec.sld.cu/en/trials/RPCEC00000363-En https://rpcec.sld.cu/en/trials/RPCEC00000359-En
10008 PiCoVacc COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Live-attenuated Approved Sinovac Biotech Ltd. 2020 China 18 - 59 years 2 doses 14 or 28 days apart Intramuscular Aluminum (alum) NA NA WHO NA Brazil, Indonesia, Turkey CoronaVac 32328406 NA https://pubmed.ncbi.nlm.nih.gov/32328406/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202686/
10009 Sinopharm Vaccine (Vero cell inactivated) COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Live-attenuated Approved Sinopharm 2020 China NA 2 doses 14 or 21 days apart Intramuscular Aluminum (alum) NA NA WHO NA Jordan, Bahrain, Morocco, UAE NA 32328406 NA https://pubmed.ncbi.nlm.nih.gov/32328406/ https://covid19.health.gov.mv/wp-content/uploads/2021/10/SINOPHARM-INFORMATION-SHEET_Final-Revised-09th-June.pdf
10010 BBIBP-CorV (Vero cell) (Covilo) COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Live-attenuated Approved China National Biotec Group Company Limited 2021 China 18 years and above 2 doses 14 or 28 days apart Intramuscular Aluminum NA NA WHO Beijing Institute of Biotechnology UAE, Jordan, Egypt, Bahrain, Argentina BBIBP-CorV, COVILO 32328406 NA https://pubmed.ncbi.nlm.nih.gov/32328406/ https://www.precisionvaccinations.com/vaccines/sinopharm-covid-19-vaccine-bbibp-corv
10011 Zifivax COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Protein subunit Approved Anhui Zhifei Longcom Biologic Pharmacy Co. Ltd. 2020 China NA 2 doses 2 to 3 days apart Intramuscular NA SARS-CoV-2 receptor-binding domain from spike protein NA China FDA Institute of Microbiology of the Chinese Academy of Sciences China, Uzbekistan, Indonesia, Pakistan, Ecuador RBD-Dimer, ZF2001 33816047 NCT04646590 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/ https://clinicaltrials.gov/ct2/show/NCT05091411
10012 SARS-CoV-2 Vaccine (VeroCell) COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Sinopharm, Beijing Institute of Biological Products 2020 China NA 2 doses 21 days apart Intramuscular NA NA NA WHO NA NA NA 33816047 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/ https://cdn.who.int/media/docs/default-source/immunization/covid-19/16-june-22080-sinopharm-vaccine-explainer-update.pdf?sfvrsn=ad833095_1&download=true
10013 Covishield COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Recombinant viral vector Approved AstraZeneca plc, University of Oxford, Serum Institute of India 2020 England NA 2 doses 28 days apart Intramuscular NA SARS-CoV-2 Spike gene to the replication defective chimpanzee adenovirus ChAdOx1 NA US FDA NA UK, USA, Japan, South Africa AZD1222,ChAdOx1 nCoV-19, ChAdOx1-S, COVID-19 Vaccine AstraZeneca, AstraZeneca COVID-19 Vaccine, AZD2816,Vaxzevria 32328406 NA https://pubmed.ncbi.nlm.nih.gov/32328406/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637436/
10014 Covishield COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA RNA based vaccine Approved AstraZeneca plc, University of Oxford, Serum Institute of India 2020 England NA NA Intramuscular NA NA mRNA based vaccine European Inclusive Vaccines Alliance NA UK, USA, Brazil, South Africa AZD1222,ChAdOx1 nCoV-19, ChAdOx1-S, COVID-19 Vaccine AstraZeneca, AstraZeneca COVID-19 Vaccine, AZD2816,Vaxzevria 33324769 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729279/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637436/
10015 Covishield COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Non-replicating viral vector Approved AstraZeneca plc, University of Oxford, Serum Institute of India NA NA NA 2 doses 4 weeks apart Intramuscular NA NA NA NA NA Argentina, India, Morocco, Britain, Mexico, El Salvador, Dominican Republic AZD1222,ChAdOx1 nCoV-19, ChAdOx1-S, COVID-19 Vaccine AstraZeneca, AstraZeneca COVID-19 Vaccine, AZD2816,Vaxzevria NA NA https://vk.ovg.ox.ac.uk/vk/covid-19-vaccines https://www.who.int/news-room/feature-stories/detail/the-oxford-astrazeneca-covid-19-vaccine-what-you-need-to-know
10016 Covishield COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Non-replicating viral vector Approved AstraZeneca plc, University of Oxford, Serum Institute of India NA NA NA 2 doses 28 days apart Intramuscular NA NA NA US FDA NA NA AZD1222,ChAdOx1 nCoV-19, ChAdOx1-S, COVID-19 Vaccine AstraZeneca, AstraZeneca COVID-19 Vaccine, AZD2816,Vaxzevria 33816047 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/ NA
10017 Convidecia COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Recombinant viral vector Approved CanSino Biologics Inc. 2020 China 6 - 59 years 2 doses Intramuscular NA Spike protein of SARS-CoV-2 virus Viral vector vaccine using a replication-defective form of the human adenovirus Ad5 NMPA Jiangsu Province Centers for Disease Control and Prevention, Insitute of Biotechnology, Academy of Military Medical Sciences, PLA of China China, Chile, Hungary, Malaysia, Mexico, Pakistan Ad5-nCoV 32328406 NCT04916886 https://pubmed.ncbi.nlm.nih.gov/32328406/ https://extranet.who.int/pqweb/vaccines/convidecia
10018 JCOVDEN COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Recombinant viral vector Approved Johnson & Johnson 2021 USA 18 - 65 years Single dose Intramuscular NA Spike protein of SARS-CoV-2 virus NA US FDA, WHO NA Netherlands, USA, Argentina, Brazil, Chile, Colombia, Mexico, Peru, Philippines, South Africa, Ukraine, Belgium, Colombia, France, Germany, Philippines, Spain, UK, Europe Ad26.COV2.S, JNJ-78436735,Ad26COVS1, VAC31518,COVID-19 Vaccine Janssen,Johnson & Johnson COVID‑19 vaccine 32328406 NCT04927936 https://pubmed.ncbi.nlm.nih.gov/32328406/ https://www.ema.europa.eu/en/documents/product-information/jcovden-previously-covid-19-vaccine-janssen-epar-product-information_en.pdf
10019 JCOVDEN COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Non-replicating viral vector Approved Janssen Pharmaceutical NA NA NA 2 doses 56 days apart Intramuscular NA NA NA US FDA NA NA Ad26.COV2.S, JNJ-78436735,Ad26COVS1, VAC31518,COVID-19 Vaccine Janssen,Johnson & Johnson COVID‑19 vaccine 33816047 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/ https://www.fda.gov/media/153439/download
10020 JCOVDEN COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Recombinant viral vector Approved Janssen Pharmaceutical 2020 Russia NA 2 doses 21 days apart Intramuscular NA Heterologous formulation consisting of two human adenovirus vectors, Ad26 and Ad5, both carrying the SARS-CoV-2 spike protein NA US FDA Health Ministry of the Russian Federation NA Ad26.COV2.S, JNJ-78436735,Ad26COVS1, VAC31518,COVID-19 Vaccine Janssen,Johnson & Johnson COVID‑19 vaccine 32328406 NA https://pubmed.ncbi.nlm.nih.gov/32328406/ NA
10021 Gam-COVID-Vac COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Recombinant viral vector Approved Gamaleya Research Institute of Epidemiology and Microbiology NA Russia NA 2 doses 3 weeks apart Intramuscular NA NA NA US FDA Health Ministry of the Russian Federation Russia, Bolivia, Argentina, Algeria, Serbia, Belarus Sputnik-V NA NA https://www.precisionvaccinations.com/vaccines/sputnik-v-vaccine NA
10022 Gam-COVID-Vac COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Recombinant viral vector Approved Gamaleya Research Institute of Epidemiology and Microbiology NA Russia NA NA Intramuscular NA NA NA EMA NA NA Sputnik-V 33324769 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729279/ NA
10023 Gam-COVID-Vac COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Non-replicating viral vector Approved Gamaleya Research Institute of Epidemiology and Microbiology NA Russia NA 2 doses 21 days apart Intramuscular NA rAd26-S, rAd5-S NA US FDA Health Ministry of the Russian Federation NA Sputnik-V 33816047 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/ NA
10024 Comirnaty COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA RNA based vaccine Approved BioNTech SE, Pfizer Inc. NA Germany 18 - 85 years NA Intramuscular NA SARS-CoV-2 spike protein mRNA encapsulated in a lipid nanoparticle NA US FDA NA USA, Argentina, Brazil, Germany, South Africa, Turkey BNT162b2, COVID-19 mRNA vaccine, Tozinameran 32328406 NA https://pubmed.ncbi.nlm.nih.gov/32328406/ https://www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_en.pdf
10025 Comirnaty COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA RNA based vaccine Approved BioNTech SE, Pfizer Inc. 2021 Germany, USA NA NA Intramuscular NA NA mRNA based vaccine US FDA NA NA BNT162b2, COVID-19 mRNA vaccine 33610448 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881713/ NA
10026 Comirnaty COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA RNA based vaccine Approved BioNTech SE, Pfizer Inc. NA USA 12 years and above 2 doses 3 weeks apart Intramuscular NA Trimerized SARS-CoV-2 receptor-binding domain from spike protein mRNA based vaccine US FDA NA Argentina, Canada, Chile, Costa Rica, Ecuador, Jordan, Kuwait, Mexico, Panama, Singapore, Bahrain, Saudi Arabia, Switzerland, European Union BNT162b2, COVID-19 mRNA vaccine, Tozinameran 33826439 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040490// https://www.comirnaty.com/
10027 Spikevax COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA RNA based vaccine Approved Moderna Inc. 2020 USA NA 2 doses Intramuscular NA SARS-CoV-2 spike protein mRNA encapsulated in a lipid nanoparticle NA US FDA NA NA mRNA-1273, CX-024414, COVID-19 mRNA Vaccine Moderna, TAK-919, Moderna COVID‑19 Vaccine, COVID‑19 Vaccine Moderna, COVID-19 Vaccine Moderna Intramuscular Injection, Elasomeran 32328406 NA https://pubmed.ncbi.nlm.nih.gov/32328406/ https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
10028 Spikevax COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA RNA based vaccine Approved Moderna Inc. NA NA NA 2 doses 28 days apart Intramuscular NA NA NA US FDA National Institute of Allergy and Infectious Diseases NA mRNA-1273, CX-024414, COVID-19 mRNA Vaccine Moderna, TAK-919, Moderna COVID‑19 Vaccine, COVID‑19 Vaccine Moderna, COVID-19 Vaccine Moderna Intramuscular Injection, Elasomeran 33816047 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/ NA
10029 Spikevax COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA RNA based vaccine Approved Moderna Inc. NA NA NA 2 doses 4 weeks apart Intramuscular NA NA NA US FDA NA USA, Canada, Israel, European Union mRNA-1273, CX-024414, COVID-19 mRNA Vaccine Moderna, TAK-919, Moderna COVID‑19 Vaccine, COVID‑19 Vaccine Moderna, COVID-19 Vaccine Moderna Intramuscular Injection, Elasomeran 33826439 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040490/ NA
10030 Covovax (Nuvaxovid) COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Protein subunit Approved Novavax Inc. NA UK NA 2 doses Intramuscular Matrix-M Spike protein of SARS-CoV-2 virus NA US FDA NA USA, Mexico TAK-019, SARS-CoV-2 rS, NVX-CoV2373 32328406 NA https://pubmed.ncbi.nlm.nih.gov/32328406/ https://clinicaltrials.gov/ct2/show/NCT05249816
10031 Covaxin COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Bharat Biotech International Limited 2021 India 18 years and above NA Intramuscular NA NA NA DCGI, WHO Indian Council of Medical Research, Iqvia Pty Ltd NA NA NA NCT04641481 https://clinicaltrials.gov/ct2/show/NCT04641481 https://www.clinicaltrialsarena.com/projects/covaxin-bbv152-for-the-treatment-of-covid-19/
10032 Covifenz COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Virus like particle Approved Medicago Inc 2021 Canada 18 years and above 2 doses 21 days apart Intramuscular AS03 NA NA Health Canada NA NA CoVLP NA NCT05040789 https://clinicaltrials.gov/ct2/show/NCT05040789 https://www.precisionvaccinations.com/vaccines/covifenz-covlp-covid-19-vaccine
10033 EpiVacCorona COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Protein subunit Approved FBRI State Research Center of Virology and Biotechnology 2020 Russia 18 years and above 2 doses 21 days apart Intramuscular Aluminum (aluminium hydroxide) SARS CoV-2 peptide antigens NA Russian Federation FBRI State Research Center of Virology and Biotechnology NA EpiVacCorona-N, Aurora-CoV 33816047 NCT04780035 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/ https://www.cnbc.com/2020/10/14/russia-approves-second-covid-19-vaccine-after-preliminary-trials-.html
10034 MVC-COV1901 COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Protein subunit Approved Medigen Vaccine Biologics, Dynavax 2021 Taiwan 12 years and above 2 doses 28 days apart Intramuscular CpG 1018, aluminium hydroxide S-2P protein NA Taiwan FDA National Institute of Allergy and Infectious Diseases Thailand, Taiwan, Paraguay NA 33816047 NCT05198596 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/ https://www.precisionvaccinations.com/vaccines/medigen-covid-19-vaccine
10035 Comirnaty COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA RNA based vaccine Approved BioNTech SE, Pfizer Inc. 2020 Germany 18 - 55 years 2 doses 21 days apart Intramuscular NA Trimerized SARS-CoV-2 receptor-binding domain from spike protein mRNA based vaccine US FDA NA Argentina, Brazil, Germany, South Africa, Turkey, USA BNT162b2, COVID-19 mRNA vaccine 33402220 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785400/ NA
10036 Spikevax COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA RNA based vaccine Approved Moderna Inc. 2020 USA 18 - 55 years 2 doses 28 days apart Intramuscular NA Spike protein of SARS-CoV-2 virus mRNA based vaccine US FDA NA NA mRNA-1273, CX-024414, COVID-19 mRNA Vaccine Moderna, TAK-919, Moderna COVID‑19 Vaccine, COVID‑19 Vaccine Moderna, COVID-19 Vaccine Moderna Intramuscular Injection, Elasomeran 33402220 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785400/ NA
10037 JCOVDEN COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Virus like particle Approved Janssen Pharmaceutical NA NA 18 years and above Single dose Intramuscular NA Spike protein of SARS-CoV-2 virus NA US FDA NA NA Ad26.COV2.S, JNJ-78436735,Ad26COVS1, VAC31518,COVID-19 Vaccine Janssen,Johnson & Johnson COVID‑19 vaccine 33402220 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785400/ NA
10038 Gam-COVID-Vac COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Virus like particle Approved Gamaleya Research Institute of Epidemiology and Microbiology 2020 Russia 18 - 60 years NA Intramuscular NA Spike protein of SARS-CoV-2 virus NA US FDA Health Ministry of the Russian Federation NA Sputnik-V 33402220 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785400/ NA
10039 Covovax (Nuvaxovid) COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Protein subunit Approved Novavax Inc. 2021 USA 12 years and above 2 doses 21 days apart Intramuscular Matrix-M1 Spike protein of SARS-CoV-2 virus NA WHO NA USA, Mexico, Puerto Rico, UK NVX-CoV2373 33402220 NCT04611802 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785400/ https://www.drugs.com/history/novavax-covid-19-vaccine.html
10040 EpiVacCorona COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Protein subunit Approved FBRI State Research Center of Virology and Biotechnology 2021 Russia 18 - 60 years 2 doses 21 or 28 days apart Intramuscular Aluminum (aluminium hydroxide) SARS-CoV-2 protein NA Russian Federation FBRI State Research Center of Virology and Biotechnology Cambodia, Russia, Turkmenistan EpiVacCorona-N, Aurora-CoV 33402220 NCT04780035 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785400/ https://clinicaltrials.gov/ct2/show/NCT04780035
10041 COVILO (BBIBP-CorV) COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved China National Biotec Group Company Limited 2021 China 3 years and above 2 doses 21 days apart Intramuscular Aluminum (aluminium hydroxide) Inactivated SARS-CoV-2 virus Inactivated SARS-CoV-2 vaccine (Vero cell) is prepared by inoculating African green monkey kidney cells (Vero cell) with the SARS-CoV-2 HB02 strain WHO, Caribbean Regulatory System Emergency Use Recommendation Beijing Institute of Biotechnology China, Bahrain, Egypt, Jordan, UAE, Hungary, Pakistan NA 33402220 NCT04863638 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785400/ https://www.carpha.org/Portals/0/Documents/COVID-19%20Vaccine%20Updates/CARPHA%20COVID-19%20Vaccine%20Update%20047%20December%206%202021.pdf
10042 PiCoVacc COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Sinovac Biotech Ltd. 2021 Brazil 18 - 59 years 2 doses 28 days apart Intramuscular NA Inactivated SARS-CoV-2 virus NA WHO, Caribbean Regulatory System Emergency Use Recommendation, Africa Regulatory Taskforce Endorsed NA NA CoronaVac 33402220 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785400/ https://www.who.int/news/item/01-06-2021-who-validates-sinovac-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations
10043 Comirnaty COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA RNA based vaccine Approved BioNTech SE, Pfizer Inc. 2021 Germany, USA NA NA Intramuscular NA NA mRNA based vaccine US FDA NA NA BNT162b2, COVID-19 mRNA vaccine NA NA https://extranet.who.int/pqweb/sites/default/files/documents/Status_of_COVID-19_Vaccines_within_WHO_EUL-PQ_evaluation_process-16June2021_Final.pdf https://www.who.int/publications/m/item/comirnaty-covid-19-mrna-vaccine#:~:text=Pfizer%2DBioNTech%20COVID%2D19%20Vaccine%2C%20COMIRNATY%C2%AE%20(Tozinameran),-COVID%2D19%20Vaccine&text=This%20vaccine%20resource%20provides%20key,disease%20(COVID%2D19).
10044 Covishield COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Recombinant viral vector Approved AstraZeneca plc, University of Oxford, Serum Institute of India 2020 UK NA NA Intramuscular NA NA Recombinant ChAdOx1 adenoviral vector encoding the Spike protein antigen of the SARS-CoV-2 EMA NA NA AZD1222,ChAdOx1 nCoV-19, ChAdOx1-S, COVID-19 Vaccine AstraZeneca, AstraZeneca COVID-19 Vaccine, AZD2816,Vaxzevria NA NA https://extranet.who.int/pqweb/sites/default/files/documents/Status_of_COVID-19_Vaccines_within_WHO_EUL-PQ_evaluation_process-16June2021_Final.pdf NA
10045 Covishield COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Recombinant viral vector Approved AstraZeneca plc, University of Oxford, Serum Institute of India NA India NA NA Intramuscular NA NA Recombinant ChAdOx1 adenoviral vector encoding the Spike protein antigen of the SARS-CoV-2 DCGI NA NA AZD1222,ChAdOx1 nCoV-19, ChAdOx1-S, COVID-19 Vaccine AstraZeneca, AstraZeneca COVID-19 Vaccine, AZD2816,Vaxzevria NA NA https://extranet.who.int/pqweb/sites/default/files/documents/Status_of_COVID-19_Vaccines_within_WHO_EUL-PQ_evaluation_process-16June2021_Final.pdf NA
10046 JCOVDEN COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Non-replicating viral vector Approved Janssen Vaccines & Prevention B.V. NA Leiden, Netherlands NA NA Intramuscular NA NA Recombinant replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding Spike protein antigen of the SARS-CoV-2 EMA NA NA Ad26.COV2.S, JNJ-78436735,Ad26COVS1, VAC31518,COVID-19 Vaccine Janssen,Johnson & Johnson COVID‑19 vaccine NA NA https://extranet.who.int/pqweb/sites/default/files/documents/Status_of_COVID-19_Vaccines_within_WHO_EUL-PQ_evaluation_process-16June2021_Final.pdf NA
10047 Spikevax COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA RNA based vaccine Approved Moderna Inc. 2020 USA NA NA Intramuscular NA NA mRNA based vaccine EMA NA NA mRNA-1273, CX-024414, COVID-19 mRNA Vaccine Moderna, TAK-919, Moderna COVID‑19 Vaccine, COVID‑19 Vaccine Moderna, COVID-19 Vaccine Moderna Intramuscular Injection, Elasomeran NA NA https://extranet.who.int/pqweb/sites/default/files/documents/Status_of_COVID-19_Vaccines_within_WHO_EUL-PQ_evaluation_process-16June2021_Final.pdf NA
10048 COVILO (BBIBP-CorV) COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Sinopharm, Beijing Institute of Biological Products NA China NA NA Intramuscular NA Inactivated SARS-CoV-2 virus Produced in vero cells NMPA, WHO NA NA Inactivated SARS-CoV-2 vaccine (Vero cell) NA NA https://cdn.who.int/media/docs/default-source/immunization/covid-19/16-june-22080-sinopharm-vaccine-explainer-update.pdf?sfvrsn=ad833095_1&download=true https://cdn.who.int/media/docs/default-source/immunization/covid-19/16-june-22080-sinopharm-vaccine-explainer-update.pdf?sfvrsn=ad833095_1&download=true
10049 CoronaVac COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Sinovac Biotech Ltd. NA China 18 years and above NA Intramuscular Aluminum (aluminium hydroxide) Inactivated SARS-CoV-2 virus Vero cells NMPA, WHO NA NA Inactivated SARS-CoV-2 Vaccine (Vero Cell) (lnCoV),CoronaVac NA NA https://extranet.who.int/pqweb/sites/default/files/documents/Status_of_COVID-19_Vaccines_within_WHO_EUL-PQ_evaluation_process-16June2021_Final.pdf https://clinicaltrials.gov/ct2/show/NCT05107557
10050 Covishield COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Recombinant viral vector Approved AstraZeneca plc, University of Oxford, Serum Institute of India NA UK NA NA Intramuscular NA NA Recombinant ChAdOx1 adenoviral vector encoding the Spike protein antigen of the SARS-CoV-2 Japan MHLW NA NA AZD1222,ChAdOx1 nCoV-19, ChAdOx1-S, COVID-19 Vaccine AstraZeneca, AstraZeneca COVID-19 Vaccine, AZD2816,Vaxzevria NA NA https://extranet.who.int/pqweb/sites/default/files/documents/Status_of_COVID-19_Vaccines_within_WHO_EUL-PQ_evaluation_process-16June2021_Final.pdf https://www.who.int/publications/m/item/chadox1-s-recombinant-covid-19-vaccine
10051 Covishield COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Recombinant viral vector Approved AstraZeneca plc, University of Oxford, Serum Institute of India NA UK NA NA Intramuscular NA NA Recombinant ChAdOx1 adenoviral vector encoding the Spike protein antigen of the SARS-CoV-2 Australia TGA NA NA AZD1222,ChAdOx1 nCoV-19, ChAdOx1-S, COVID-19 Vaccine AstraZeneca, AstraZeneca COVID-19 Vaccine, AZD2816,Vaxzevria NA NA https://extranet.who.int/pqweb/sites/default/files/documents/Status_of_COVID-19_Vaccines_within_WHO_EUL-PQ_evaluation_process-16June2021_Final.pdf https://www.who.int/publications/m/item/chadox1-s-recombinant-covid-19-vaccine
10052 Covovax (Nuvaxovid) COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Subunit vaccine Approved Novavax Inc. 2020 USA NA NA Intramuscular NA NA Recombinant nanoparticle prefusion spike protein formulated with Matrix adjuvant EMA, WHO NA NA TAK-019, SARS-CoV-2 rS, NVX-CoV2373 NA NA https://extranet.who.int/pqweb/sites/default/files/documents/Status_of_COVID-19_Vaccines_within_WHO_EUL-PQ_evaluation_process-16June2021_Final.pdf https://www.who.int/news-room/feature-stories/detail/the-novavax-vaccine-against-covid-19-what-you-need-to-know
10053 Covaxin COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Bharat Biotech International Limited NA India NA NA Intramuscular NA NA Produced in vero cells DCGI NA NA NA NA NA https://extranet.who.int/pqweb/sites/default/files/documents/Status_of_COVID-19_Vaccines_within_WHO_EUL-PQ_evaluation_process-16June2021_Final.pdf https://www.precisionvaccinations.com/vaccines/covaxin-covid-19-vaccine
10054 EpiVacCorona COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Protein subunit Approved Vector State Research Centre of Viralogy and Biotechnology NA Russia NA NA Intramuscular NA NA NA Russian Federation NA Russia, Cambodia EpiVacCorona-N, Aurora-CoV NA NCT04780035 https://www.cnbc.com/2020/10/14/russia-approves-second-covid-19-vaccine-after-preliminary-trials-.html https://www.precisionvaccinations.com/vaccines/epivaccorona-vaccine#:~:text=EpiVacCorona%20(Aurora%2DCoV)%20is,19%20and%20promotes%20immunity%20development.
10055 Zifivax COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Protein subunit Approved Anhui Zhifei Longcom Biologic Pharmacy Co. Ltd. NA China NA NA Intramuscular NA NA Recombinant UAE NA NA Recombinant Novel Coronavirus Vaccine CHO Cell) NA NCT04550351 https://clinicaltrials.gov/ct2/show/NCT04550351 https://trialsearch.who.int/Trial2.aspx?TrialID=NCT04646590
10056 Pasteur COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Protein subunit Approved BioCubaFarma 2021 Cuba NA NA Intramuscular NA Spike protein of SARS-CoV-2 virus NA CECMED NA NA FINLAY-FR-2, Pasteurcovac, Pasto Covac, Soberana 02 NA NA https://extranet.who.int/pqweb/sites/default/files/documents/Status_of_COVID-19_Vaccines_within_WHO_EUL-PQ_evaluation_process-16June2021_Final.pdf https://rpcec.sld.cu/trials/RPCEC00000354-En
10057 Corbevax COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Subunit vaccine Approved Biological E Limited 2021 India 18 - 65 years 2 doses 28 days apart Intramuscular NA NA NA NA NA NA BECOV2A NA NA http://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48329&EncHid=&userName=covid-19%20vaccine NA
10058 TAK-019 COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Protein subunit Approved Takeda Pharmaceutical Company Limited 2021 USA 20 years and above 2 doses 21 days apart Intramuscular NA NA NA US FDA, Japan MHLW NA Indonesia, Philippines, Japan NA NA NCT05299359 https://clinicaltrials.gov/ct2/show/NCT05299359 NA
10059 VLA2001 COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Valneva 2021 Austria 18 years and above 2 doses 28 days apart Intramuscular CpG 1018, aluminium hydroxide NA NA EMA NA NA NA NA NCT04864561 https://clinicaltrials.gov/show/NCT04864561 https://valneva.com/press-release/valneva-receives-marketing-authorization-in-europe-for-inactivated-whole-virus-covid-19-vaccine-vla2001/#:~:text=VLA2001%20is%20the%20only%20whole,to%2050%20years%20of%20age.
10060 JCOVDEN COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Non-replicating viral vector Approved Janssen Pharmaceutical 2020 USA 18 years and above NA Intramuscular NA NA NA US FDA, WHO, Africa Regulatory Taskforce Endorsed, Caribbean Regulatory System Emergency Use Recommendation NA Argentina, Brazil, Chile, Colombia, Mexico, Peru, Philippines, South Africa, Ukraine, USA Ad26.COV2.S, JNJ-78436735,Ad26COVS1, VAC31518,COVID-19 Vaccine Janssen,Johnson & Johnson COVID‑19 vaccine NA NCT04436276 https://clinicaltrials.gov/show/NCT04436276 NA
10061 Razi Cov Pars COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Subunit vaccine Approved Razi Vaccine, Serum Research Institute 2021 Iran 18 years and above 2 doses 21 days apart Intramuscular NA NA NA Iran FDA NA NA NA NA NA https://www.irct.ir/trial/58143 NA
10062 SpikoGen COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Subunit vaccine Approved Vaxine, CinnaGen 2021 Iran 18 years and above 2 doses 21 days apart Intramuscular Advax-SM Spike protein of SARS-CoV-2 virus NA Iran FDA NA NA NA NA NCT05005559 https://covid19.trackvaccines.org/vaccines/8/ NA
10063 COVIran Barekat COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Shifa Pharmed Industrial Co. 2021 Iran 18 - 75 years 2 doses 28 days apart Intramuscular NA NA NA Iran FDA NA NA NA NA NA https://en.irct.ir/trial/54881 https://www.rferl.org/a/iran-domestic-covid-vaccine-coviran-barekat/31307467.html
10064 FINLAY-FR-2 COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Subunit vaccine Approved Instituto Finlay de Vacunas 2021 Cuba 19 years and above NA Intramuscular NA NA NA CECMED NA Iran, Cuba Soberana 02 NA NA https://www.cecmed.cu/noticias/aprueba-cecmed-autorizo-uso-emergencia-vacunas-cubanas-soberana-02-soberana-plus NA
10065 ZyCoV-D COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA DNA based vaccine Approved Zydus Candila Healthcare Limited 2021 India 12 years and above NA Intradermal NA SARS CoV-2 envelope protein NA DCGI NA India NA NA NA https://pib.gov.in/PressReleasePage.aspx?PRID=1747669#:~:text=Zydus%20Cadila%20has%20received%20approval,adults%2012%20years%20and%20above. NA
10066 FAKHRAVAC COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Erciyes University, Organization of Defensive Innovation and Research 2021 Iran 18 - 70 years NA Intramuscular NA SARS-CoV-2 NA Iran FDA Organization of Defensive Innovation and Research NA MIVAC, TURKOVAC NA NA https://en.irct.ir/trial/56027 https://www.tehrantimes.com/news/466570/Two-homegrown-vaccines-receive-emergency-use-license
10067 KCONVAC COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Inactivated Approved Shenzhen Kangtai Biological Products Co. Ltd 2021 China 18 years and above 2 doses 28 days apart Intramuscular NA NA NA China FDA Beijing Minhai Biotechnology Co. China, Indonesia NA NA NCT05204589 https://clinicaltrials.gov/ct2/show/NCT05204589 https://www.reuters.com/article/us-health-coronavirus-vaccine-kangtai/kangtai-biologicals-covid-19-vaccine-gets-emergency-use-approval-in-china-idUSKBN2CV1F6
10068 Afluria Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved Seqirus 2007 Australia 6 months - 35 months NA Intramuscular NA NA Egg based US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10069 Afluria Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved Seqirus 2007 Australia 3 years and above NA Intramuscular NA NA Egg based US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10070 Afluria Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved Seqirus NA NA 6 months - 64 years NA Intramuscular Thimerosal (24.5) Mercury NA Egg based US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10071 Fluarix Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved GlaxoSmithKline NA NA 6 months and above Single dose Intramuscular NA Hemagglutinin Egg based US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10072 FluLaval Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved GlaxoSmithKline NA NA 7 months and above Single dose Intramuscular NA Hemagglutinin Egg based US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10073 Fluzone Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved Sanofi Pasteur NA NA 8 months and above Single dose Intramuscular NA Hemagglutinin Egg based US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10074 Fluzone Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved Sanofi Pasteur NA NA 9 months and above NA Intramuscular NA Hemagglutinin Egg based US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10075 Fluzone Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved Sanofi Pasteur NA NA 10 months and above NA Intramuscular Thimerosal (24.5) Mercury Hemagglutinin Egg based US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10076 Flucelvax Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved Seqirus NA NA 4 years and above Single dose Intramuscular NA Hemagglutinin Cell culture based US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10077 Flucelvax Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved Seqirus NA NA 4 years and above NA Intramuscular Thimerosal (24.5) Mercury Hemagglutinin Cell culture based US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10078 Fluzone High-Dose Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved Sanofi Pasteur NA NA 65 years and above Single dose Intramuscular NA Hemagglutinin Egg based US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10079 Fluad Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved Seqirus NA NA 65 years and above Single dose Intramuscular MF59 Hemagglutinin Egg based US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10080 Fluad Trivalent IIV (IIV3) Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved Seqirus NA NA 65 years and above Single dose Intramuscular MF59 Hemagglutinin Egg based US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10081 Flublok Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Live-attenuated Approved Sanofi Pasteur 2013 NA 18 years and above Single dose Intramuscular NA Hemagglutinin NA US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10082 FluMist Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Live-attenuated Approved AstraZeneca plc 2003 Canada 2 - 49 years Single dose Intranasal NA Hemagglutinin Egg based US FDA NA NA Tamiflu, Relenza NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10083 IL-YANG Quadrivalent Seasonal Influenza Vaccine Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved Ilyang pharmaceutical Co. Ltd. 2020 South Korea 3 - 18 years Single dose Intramuscular NA Inactivated Influenza virus NA MFDS NA NA NA NA NCT03445468 https://clinicaltrials.gov/ct2/show/NCT03445468?recrs=ade&cond=Influenza%2C+Human&phase=23&draw=2&rank=4 https://www.clincosm.com/trial/influenza-il-yang-quadrivalent-vaccine-flu-prefilled-syringe
10084 ERVEBO Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Live-attenuated Approved Merck & Co. Inc. 2019 USA 18 years and above Single dose Intramuscular NA Zaire Ebola virus glycoprotein NA US FDA, EMA NA NA V920, rVSV-G-ZEBOV-GP, rVSV-ZEBOV NA NA https://www.cdc.gov/vhf/ebola/clinicians/vaccine/index.html https://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2817%2930313-4/fulltext
10085 Ad26.ZEBOV Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Recombinant viral vector Approved Janssen Pharmaceutical 2020 USA 1 year and above Single dose of Zabdeno on day 0 followed by 0.5mL dose of Mvabea post 8 week Intramuscular NA Adenovirus type 26 encoding the Zaire ebolavirus, Mayinga variant glycoprotein NA US FDA, EMA NA NA MVA-BN-Filo NA NCT02509494 https://clinicaltrials.gov/ct2/show/NCT02509494 https://clinicaltrials.gov/ct2/show/NCT05284097
10086 YF-Vax Yellow fever Hemorrhagic Yellow fever virus positive-sense, single-stranded RNA Live-attenuated Approved Sanofi Pasteur NA France 9 months and above Single dose Subcutaneous NA 17D-204 strain of yellow fever virus Culturing 17D-204 strain of yellow fever virus in living avian leukosis virus-free (ALV-free) chicken embryos US FDA NA NA NA NA NA https://www.fda.gov/media/76015/download https://www.fda.gov/media/76015/download
10087 CYD-TDV Dengvaxia Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Live-attenuated Approved Sanofi Pasteur 2015 France 9 - 45 years 3 doses 6 months apart Subcutaneous NA Dengue virus serotypes (1, 2, 3 and 4) 17D vaccine vector expressing genes of DENV-1, 2, 3, or 4 US FDA NA NA NA 30684747 NCT02747927 https://www.sciencedirect.com/science/article/pii/S1201971219300402 https://www.fda.gov/media/124379/download
10088 Weisairuiji Biovac-A Mevac-A Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Live-attenuated Approved Biogenetech Co. Ltd., Zhejiang Pukang Biotechnology Co. Ltd. 2010 Thailand 1.5 years and above Single dose Subcutaneous NA H2 strain of HAV H2-attenuated strain of HAV cultured in human diploid cells. China FDA, US FDA NA NA MEVAC-A 24280971 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130259/ https://apps.who.int/iris/bitstream/handle/10665/326501/97892516327-eng.pdf
10089 Weisairuiji Biovac-A Mevac-A Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Live-attenuated Approved Institute of Medical Biology, Chinese Academy of Medical Sciences NA China NA Single dose Subcutaneous NA H2 strain of HAV NA China FDA, US FDA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.fda.moph.go.th/sites/drug/Shared%20Documents/Vaccine/U1DR1C1072530000811C-SPC.pdf
10090 HAVAC Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Live-attenuated Approved Changchun Institute of Biological Products NA China NA Single dose Subcutaneous NA LA-1 NA Government of Canada Changchun Changsheng Life Sciences NA NA 24280971 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130259/ https://www.canada.ca/en/public-health/services/publications/healthy-living/update-recommended-use-hepatitis-b-vaccine.html
10091 HAVAC Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Live-attenuated Approved Changchun Institute of Biological Products NA China NA Single dose Subcutaneous NA LA-1 NA Government of Canada Changchun Changsheng Life Sciences NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.canada.ca/en/public-health/services/publications/healthy-living/update-recommended-use-hepatitis-b-vaccine.html
10092 HAVRIX Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved GlaxoSmithKline NA Belgium NA P: 720 EU; Adults: 1440 EU; 2 doses 0, 6–12 Intramuscular Aluminum (aluminium hydroxide) HM-175 NA US FDA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/Package-Insert---HAVRIX.pdf
10093 VAQTA Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved Merck & Co. Inc. NA USA NA P: 25 U; Adults: 50 U; 2 doses 0, 6–18 Intramuscular Aluminum (aluminium hydroxide) CR-326 NA US FDA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.fda.gov/vaccines-blood-biologics/vaccines/vaqta
10094 AVAXIM Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved Sanofi Pasteur NA Lyon, France NA P: 80 U; Adults: 160 U Intramuscular Aluminum (aluminium hydroxide) GBM NA US FDA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.fda.moph.go.th/sites/drug/Shared%20Documents/Vaccine/U1DR1C1062460010911C-SPC.pdf
10095 Healive Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved Sinovac Biotech Ltd. NA China NA P: 250 U; Adults: 500 U Intramuscular Aluminum (aluminium hydroxide) TZ-84 NA China FDA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ http://www.sinovac.com/news/shownews.php?id=764&lang=en
10096 Weisairuiji Biovac-A Mevac-A Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved Institute of Medical Biology, Chinese Academy of Medical Sciences NA China NA P: 320 EU; Adults: 640 EU Intramuscular Aluminum (aluminium hydroxide) Lv-8 NA China FDA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482852/
10097 Veraxim Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved Shanghai Wilson Bioengineering NA China NA P: 800 EU; Adults: 1600 EU Intramuscular Aluminum (aluminium hydroxide) YN-5 NA Government of China NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/
10098 HAVRIX Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved GlaxoSmithKline NA Belgium 12 months and above Single dose for adult and 2 doses 6 to 12 months apart for infants Intramuscular NA NA NA US FDA NA NA NA NA NA https://www.cdc.gov/hepatitis/hav/havfaq.htm#vaccine https://www.fda.gov/vaccines-blood-biologics/vaccines/havrix
10099 VAQTA Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Inactivated Approved Merck & Co. Inc. NA USA 12 months and above 2 doses 6 to 18 months apart Intramuscular NA NA NA US FDA NA NA NA NA NA https://www.cdc.gov/hepatitis/hav/havfaq.htm#vaccine https://www.fda.gov/vaccines-blood-biologics/vaccines/vaqta
10100 TWINRIX Hepatitis A, Hepatitis B Hepatitic Hepatitis A, Hepatitis B virus positive-sense, single-stranded RNA Inactivated Approved GlaxoSmithKline NA Rixensart, Belgium 18 years and above 3 doses at regimen of 0, 1, and 6 months Intramuscular Aluminum Strain HM175, HBsAg NA US FDA NA NA NA NA NA https://www.cdc.gov/hepatitis/hav/havfaq.htm#vaccine https://www.fda.gov/vaccines-blood-biologics/vaccines/twinrix
10101 ENGERIX-B Hepatitis B Hepatitic Hepatitis B virus double stranded DNA DNA based vaccine Approved GlaxoSmithKline NA Rixensart, Belgium All age group 3 doses at regimen of 0, 1, and 6 months Intramuscular NA HBsAg NA US FDA NA NA NA NA NA https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#vaccFAQ https://www.fda.gov/vaccines-blood-biologics/vaccines/engerix-b
10102 RECOMBIVAX HB Hepatitis B Hepatitic Hepatitis B virus double stranded DNA Protein subunit Approved Merck & Co. Inc. NA USA All age group 2 doses 6 months apart Intramuscular NA HBsAg NA US FDA NA NA NA NA NA https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#vaccFAQ https://www.fda.gov/vaccines-blood-biologics/vaccines/recombivax-hb
10103 HEPLISAV-B Hepatitis B Hepatitic Hepatitis B virus double stranded DNA Subunit vaccine Approved Dynavax NA NA 18 years and above 2 doses 1 month apart Intramuscular CpG HepB NA US FDA NA NA NA NA NA https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#vaccFAQ https://www.fda.gov/vaccines-blood-biologics/vaccines/heplisav-b
10104 PEDIARIX Hepatitis B, Diphtheria, Tetanus, Acellular pertussis , Poliomyelitis Hepatitic Hepatitis B virus double stranded DNA NA Approved GlaxoSmithKline NA USA 6 weeks - 7 years 2 doses 6 months apart Intramuscular NA HBsAg NA US FDA NA NA NA NA NA https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#vaccFAQ https://www.fda.gov/vaccines-blood-biologics/vaccines/pediarix
10105 HBVaxPRO Hepatitis B Hepatitic Hepatitis B virus double stranded DNA Subunit vaccine Approved Sanofi Pasteur NA USA 18 years and above NA Intramuscular NA HBsAg NA EMA NA NA NA 26208678 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685678/ https://www.ema.europa.eu/en/documents/overview/hbvaxpro-epar-summary-public_en.pdf
10106 Fendrix Hepatitis B Hepatitic Hepatitis B virus double stranded DNA NA Approved GlaxoSmithKline NA Belgium NA NA Intradermal, Intravenous AS043 HBsAg NA US FDA NA NA NA 26208678 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685678/ https://www.ema.europa.eu/en/medicines/human/EPAR/fendrix
10107 Hecolin (Hepatitis vaccine -239) Hepatitis E Hepatitic Hepatitis E virus double stranded DNA Virus like particle Approved Xiamen Innovax Biotech 2011 China NA 3 doses at regimen of 0, 1, and 6 months Intramuscular NA HEV-1 Chinese strain NA China FDA NA NA NA 27610014 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988308/ https://www.precisionvaccinations.com/vaccines/hecolin-hepatitis-e-vaccine
10108 Hecolin (Hepatitis vaccine -239) Hepatitis E Hepatitic Hepatitis E virus double stranded DNA Recombinant viral vector Approved Xiamen Innovax Biotech 2011 China NA 3 doses at regimen of 0, 1, and 6 months Intramuscular Aluminum (aluminium hydroxide) Capsid Protein ORF2 NA China FDA NA NA Hecolin 29546064 NCT01014845 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818934/ https://www.precisionvaccinations.com/vaccines/hecolin-hepatitis-e-vaccine
10109 AMBIRIX Hepatitis A, Hepatitis B Hepatitic Hepatitis A, Hepatitis B virus double stranded DNA Inactivated Approved GlaxoSmithKline 2002 Belgium 1 - 15 years 2 doses 6 to 12 months apart Intramuscular Aluminum (aluminium hydroxide) Inactivated hepatitis A virus and surface antigen of hepatitis B virus Produced on human diploid (MRC-5) cells EMA NA NA NA NA NA https://www.ema.europa.eu/en/documents/product-information/ambirix-epar-product-information_en.pdf https://www.ema.europa.eu/en/documents/product-information/ambirix-epar-product-information_en.pdf
10110 AMBIRIX Hepatitis A, Hepatitis B Hepatitic Hepatitis A, Hepatitis B virus double stranded DNA Inactivated Approved GlaxoSmithKline 2002 Belgium 2 - 15 years 2 doses 6 to 12 months apart Intramuscular Aluminum (aluminum phosphate) Inactivated hepatitis A virus and surface antigen of hepatitis B virus Produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology EMA NA NA NA NA NA https://www.ema.europa.eu/en/documents/product-information/ambirix-epar-product-information_en.pdf https://www.ema.europa.eu/en/documents/product-information/ambirix-epar-product-information_en.pdf
10111 VIVAXIM Hepatitis A, Typhoid Hepatitic Hepatitis A virus, Salmonella typhi double stranded DNA NA Approved Sanofi Pasteur 2007 France 16 years and above Single dose Intramuscular Aluminum (aluminium hydroxide) Salmonella typhi Vi polysaccharide (Ty 2 strain) and formaldehyde inactivated hepatitis A virus antigen (GBM strain) GBM strain cultured on MRC-5 human diploid cells Government of Canada NA NA VIATIM NA NA http://products.sanofi.com.au/vaccines/VIVAXIM_NZ_PI.pdf https://pdf.hres.ca/dpd_pm/00032177.PDF
10112 Imovax Rabies(Pre exposure) Rabies Neurologic Rabies virus negative-sense, single-stranded RNA Inactivated Approved Sanofi Pasteur 2005 France All age group 3 doses on day 0, 7 and 21 Intramuscular NA WISTAR Rabies PM/WI38-1503-3M strain Human diploid cell vaccine US FDA NA NA NA NA NA https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref https://www.fda.gov/vaccines-blood-biologics/vaccines/imovax
10113 Imovax Rabies(Post exposure) Rabies Neurologic Rabies virus negative-sense, single-stranded RNA Inactivated Approved Sanofi Pasteur 2005 France All age group 5 doses on day 0, 3, 7, 14 and 28 Intramuscular NA WISTAR Rabies PM/WI38-1503-3M strain Human diploid cell vaccine US FDA NA NA NA NA NA https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref https://www.fda.gov/vaccines-blood-biologics/vaccines/imovax
10114 RabAvert Rabies Neurologic Rabies virus negative-sense, single-stranded RNA Inactivated Approved Novartis NA NA All age group 4 doses on day 0, 3, 7 and 14 Intramuscular NA NA Purified chick embryo cell US FDA NA NA NA NA NA https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref https://www.fda.gov/files/vaccines%2C%20blood%20&%20biologics/published/Package-Insert---RabAvert.pdf
10115 Imogam Rabies-HT Rabies Neurologic Rabies virus negative-sense, single-stranded RNA Inactivated Approved Sanofi Pasteur NA NA All age group 4 doses on day 0, 7 and 21 or 28 Intramuscular NA NA Rabies Immunoglobin Government of Canada NA NA NA NA NA https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref https://www.sanofi.ca/dam/jcr:21c480e0-afcd-4a38-bfee-fb9b7a6b21e0/imogam-rabies-pasteurized.pdf
10116 HyperRabTM S/D Rabies Neurologic Rabies virus negative-sense, single-stranded RNA Inactivated Approved Talecris Biotherapeutics Bayer Biological Products NA NA NA NA Intramuscular NA NA Rabies Immunoglobin US FDA NA NA NA NA NA https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref https://www.hyperrab.com/en/hcp
10117 Verorab Rabies Neurologic Rabies virus negative-sense, single-stranded RNA Inactivated Approved Sanofi Pasteur 2015 France NA 5 doses on day 0, 3, 7, 14 and 28 Intramuscular NA WISTAR Rabies PM/WI38-1503-3M strain Purified vero cell rabies vaccine DCGI NA NA NA NA NA https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref https://ncdc.gov.in/WriteReadData/l892s/File557.pdf
10118 Lyssavac N Rabies Neurologic Rabies virus negative-sense, single-stranded RNA Inactivated Approved Zydus Candila Healthcare Limited NA India NA 3 doses on day 0, 7 and 21 Intramuscular NA NA Purified duck embryo cell WHO Berna Biotech NA NA NA NA https://www.fda.moph.go.th/sites/drug/Summary/1C_278_50_Lyssavac%20N%20Injection.pdf https://www.livemint.com/Companies/XopdfNnBp4Y6189QY3PY2N/Zydus-Cadila-receives-WHO-nod-for-rabies-vaccine.html
10119 Rabipur Rabies Neurologic Rabies virus negative-sense, single-stranded RNA Inactivated Approved GlaxoSmithKline NA NA All age group 3 doses on day 0, 7 and 21 Intramuscular NA NA Purified chick embryo cell DCGI NA NA NA NA NA https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref https://www.wbhealth.gov.in/uploaded_files/IDSP/Guideline_Rabies_prophylaxis_PPT_PDF.pdf
10120 Rabivax-S Rabies Neurologic Rabies virus negative-sense, single-stranded RNA Inactivated Approved Ross University School of Veterinary Medicine 2019 India All age group 3 doses on day 0, 7 and 21 Intramuscular NA NA Human diploid cell vaccine DCGI Serum Institute of India NA NA NA NCT03741270 https://clinicaltrials.gov/ct2/show/NCT03741270 http://test.pharmabiz.com/news/serum-institute-launches-rabies-vaccine-rabivax-24382
10121 KAMRAB-003 Rabies Neurologic Rabies virus negative-sense, single-stranded RNA Live-attenuated Approved Kamada Ltd. 2014 USA 18 - 75 years 5 doses on day 0, 3, 7, 14 and 28 Intramuscular NA NA NA US FDA NA NA NA NA NCT02040090 https://clinicaltrials.gov/ct2/show/NCT02040090?cond=Rabies+Human&phase=23&draw=2&rank=5 https://pdf.hres.ca/dpd_pm/00048173.PDF
10122 Speeda Rabies Neurologic Rabies virus negative-sense, single-stranded RNA Inactivated Approved Beijing Center for Disease Control and Prevention 2013 China NA 3 doses on day 0, 7 and 21 Intramuscular NA NA NA Thailand FDA NA NA NA NA NCT01821911 https://clinicaltrials.gov/ct2/show/NCT01821911?cond=Rabies+Human&phase=23&draw=2&rank=7 https://www.immunize.org/askexperts/experts_rab.asp
10123 SA14-14-2 (IXIARO) Viral encephalitis Neurologic West Nile virus positive-sense, single-stranded RNA Live-attenuated Approved Sanofi Pasteur 2013 Thailand NA NA Subcutaneous NA SA 14-14-2 Cell culture based NA NA NA NA 24161909 NCT01092507 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/ https://www.fda.gov/media/75777/download
10124 ENCEVAC Viral encephalitis Neurologic West Nile virus positive-sense, single-stranded RNA Inactivated Approved Research Foundation for Microbial Diseases of Osaka University NA NA NA NA Subcutaneous NA Beijing-1(P1) Cell culture based NA NA NA JEBIK V (BIKEN), KD-287, JEIMMUGEN INJ (Kaketsuken) 24161909 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/ https://ifli.wisc.edu/wp-content/uploads/sites/528/2019/05/Japanese-Encephalitis.pdf
10125 IXIARO Viral encephalitis Neurologic West Nile virus positive-sense, single-stranded RNA Inactivated Approved Valneva NA UK 2 months and above 2 doses 28 days apart Intramuscular Aluminum (aluminium hydroxide) Beijing-3(P3), SA14-14-2 Cell culture based US FDA NA New Zealand, Europe, India, China, US, Japan IC51, JESPECT, JEEV (Intercell AG) in Australia 24161909 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/ https://www.fda.gov/vaccines-blood-biologics/vaccines/ixiaro
10126 IMOJEV Viral encephalitis Neurologic West Nile virus positive-sense, single-stranded RNA Live-attenuated Approved Sanofi Pasteur 2017 Thailand 9 months and above 3 doses Subcutaneous NA SA 14-14-2 Mouse brain based US FDA NA NA ChimeriVax-JE, JE-CV, THAIJEV (Sanofi-Aventis) 24161909 NCT01900444 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/ https://www.fda.gov/vaccines-blood-biologics/vaccines/japanese-encephalitis-vaccine-inactivated-adsorbed
10127 IPOL Poliomyelitis Neurologic Poliovirus positive-sense, single-stranded RNA Inactivated Approved Sanofi Pasteur NA NA 6 months and above 2-3 doses depending on volume and age Intramuscular NA P1, P2 and P3 Monkey kidney cell US FDA NA NA NA NA NA https://www.fda.gov/vaccines-blood-biologics/vaccines/ipol-poliovirus-vaccine-inactivated-monkey-kidney-cell NA
10128 KINRIX Poliomyelitis Neurologic Poliovirus positive-sense, single-stranded RNA Inactivated Approved GlaxoSmithKline 2008 NA 4 - 6 years 5 doses Intramuscular NA P1, P2 and P4 NA US FDA NA NA NA NA NA https://www.fda.gov/vaccines-blood-biologics/vaccines/kinrix NA
10129 PEDIARIX Poliomyelitis Neurologic Poliovirus positive-sense, single-stranded RNA Inactivated Approved GlaxoSmithKline 2002 NA 6 weeks - 6 years 3 doses at regimen of 2, 4, and 6 months of age. Intramuscular NA P1, P2 and P5 NA US FDA NA NA NA NA NA https://www.fda.gov/vaccines-blood-biologics/vaccines/pediarix NA
10130 Pentacel Poliomyelitis Neurologic Poliovirus positive-sense, single-stranded RNA Inactivated Approved Sanofi Pasteur 2008 NA 6 weeks - 4 years 4 doses at regimen of 2, 4, 6 and 15-18 months of age Intramuscular NA P1, P2 and P6 NA US FDA NA NA NA NA NA https://www.fda.gov/vaccines-blood-biologics/vaccines/pentacel NA
10131 ACAM2000 Smallpox Exanthous Variola virus double stranded DNA Live-attenuated Approved Emergent BioSolutions 2003 USA Below 12 months of age Single dose Percutaneous NA Recombinant vaccinia viruses derived from replication-competent vaccinia strain Lyophilized US FDA NA NA NA NA NA https://www.fda.gov/vaccines-blood-biologics/vaccines/acam2000 NA
10132 JYNNEOS Smallpox Exanthous Variola virus double stranded DNA Live-attenuated Approved Bavarian Nordic NA Denmark 18 years and above 2 doses 4 weeks apart Subcutaneous NA Vaccinia Virus Ankar NA US FDA NA NA Imvamune, Imvanex, MVA-BN NA NA https://www.fda.gov/vaccines-blood-biologics/jynneos https://www.fda.gov/media/131078/download
10133 Aventis Pasteur Smallpox Vaccine Smallpox Exanthous Variola virus double stranded DNA Live-attenuated Approved National Institute of Allergy and Infectious Diseases 2010 USA 18 - 32 years NA Percutaneous NA NA NA US FDA NA NA NA NA NCT00038987 https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/smallpox-preparedness-and-response-updates-fda https://clinicaltrials.gov/ct2/show/NCT00038987
10134 Priorix Measles, Mumps, Rubella, Chickenpox Exanthous Morbillivirus, Mumps virus, Rubella virus, Varicella-zoster virus negative-sense, single-stranded RNA Live-attenuated Approved GlaxoSmithKline 2019 NA 11 months - 22 months 2 doses 42 days apart Subcutaneous NA Vaccinia Virus NA NA NA NA NA NA NCT00226499 https://www.fda.gov/vaccines-blood-biologics/priorix https://clinicaltrials.gov/ct2/show/NCT00226499
10135 Varivax Chickenpox Exanthous Varicella-zoster virus double stranded DNA Live-attenuated Approved Merck & Co. Inc. 2007 USA 1 - 12 years 2 doses (0.5 ml each) separated by at least 3 months.# First dose: age 12 through 15 months, Second dose: age 4 through 6 years Subcutaneous NA Oka/Merck strain of live-attenuated varicella virus NA US FDA NA NA NA NA NCT00822237 https://www.cdc.gov/vaccines/vpd/varicella/index.html https://www.fda.gov/vaccines-blood-biologics/vaccines/varivax
10136 Varivax Chickenpox Exanthous Varicella-zoster virus double stranded DNA Live-attenuated Approved Merck & Co. Inc. 2007 USA 12 - 23 months 2 doses 4 weeks apart Subcutaneous NA Oka/Merck strain of live-attenuated varicella virus NA US FDA NA NA NA NA NA https://www.cdc.gov/vaccines/vpd/varicella/index.html https://www.fda.gov/vaccines-blood-biologics/vaccines/varivax
10137 ProQuad Measles, Mumps, Rubella, Varicella Exanthous Morbillivirus, Mumps virus, Rubella virus, Varicella-zoster virus negative-sense, single-stranded RNA Live-attenuated Approved Merck & Co. Inc. NA USA 1 - 12 years First dose at 12 through 15 months of age and Second dose at 4 through 6 years of age Subcutaneous NA NA NA US FDA NA NA NA NA NCT00985166 https://www.cdc.gov/vaccines/vpd/varicella/index.html https://www.fda.gov/vaccines-blood-biologics/vaccines/proquad
10138 RotaTeq (RV5) Rotavirus Infection Gastrointestinal Rotavirus double stranded RNA Live-attenuated Approved Merck & Co. Inc. NA USA 6 months - 8 months 3 doses at age of 2 months, 4 months, and 6 months Oral NA 5 human-bovine reassortant rotaviruses (G1, G2, G3 G4, P[8]) NA US FDA NA NA NA NA NA https://www.cdc.gov/vaccines/vpd/rotavirus/index.html https://www.fda.gov/media/75718/download
10139 Rotarix (RV1) Rotavirus Infection Gastrointestinal Rotavirus double stranded RNA Live-attenuated Approved GlaxoSmithKline 2006 UK 6 months - 8 months 2 doses at ages 2 months and 4 months Oral NA Human rotavirus strain (G1P[8]) NA US FDA, EMA NA NA NA NA NA https://www.cdc.gov/vaccines/vpd/rotavirus/index.html https://www.fda.gov/vaccines-blood-biologics/vaccines/rotarix
10140 Rotavac Rotavirus Infection Gastrointestinal Rotavirus double stranded RNA Live-attenuated Approved Bharat Biotech International Limited 2013 India 6 months - 8 months 3 doses 4 weeks apart Oral NA Rotavirus 116E strain NA US FDA, Government of India NA NA NA NA NA https://www.who.int/immunization/research/meetings_workshops/11_Cassels_Rotavirus_PDVAC_2019.pdf?ua=1 https://www.fda.gov/vaccines-blood-biologics/vaccines/rotavirus-vaccine-live-oral
10141 RotaSiil Rotavirus Infection Gastrointestinal Rotavirus double stranded RNA Live-attenuated Approved Serum Institute of India 2017 India 6 months - 8 months 3 doses 4 weeks apart Oral NA Human-bovine reassortant rotaviruses (G1, G2, G3, G4, G9) NA National Institute of Health, Government of India NA NA NA NA NA https://www.who.int/immunization/research/meetings_workshops/11_Cassels_Rotavirus_PDVAC_2019.pdf?ua=1 https://www.fda.gov/vaccines-blood-biologics/vaccines/rotarix
10142 BL 125296 Adenovirus Infection Respiratory Adenovirus Type 4, Type 7 double stranded DNA Live-attenuated Approved Barr Pharmaceuticals Inc. NA USA 17 - 50 years 2 doses Oral NA Live adenovirus NA US FDA NA NA NA NA NA https://www.fda.gov/media/80211/download https://www.fda.gov/vaccines-blood-biologics/vaccines/adenovirus-type-4-and-type-7-vaccine-live-oral
10143 Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted Influenza (flu) Respiratory Influenza A virus H5N1 positive-sense, single-stranded RNA Inactivated Approved ID Biomedical Corporation of Quebec 2013 USA 6 months and above 2 doses 21 days apart Intramuscular AS03 A/H5N1 influenza antigen NA US FDA NA NA NA NA NA https://www.fda.gov/media/87479/download https://www.fda.gov/vaccines-blood-biologics/vaccines/influenza-h5n1-virus-monovalent-vaccine-adjuvanted
10144 AUDENZ Influenza (flu) Respiratory Influenza A virus H5N1 positive-sense, single-stranded RNA Inactivated Approved Seqirus 2020 USA 6 months and above 2 doses 21 days apart Intramuscular MF59 Influenza virus strain A/turkey/Turkey/1/2005-NIBRG-23 NA US FDA NA NA NA NA NA https://www.fda.gov/media/135020/download https://www.fda.gov/vaccines-blood-biologics/audenz
10145 Fluvirin Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Inactivated Approved Seqirus NA USA 4 years and above 2 doses at least 1 month apart Intramuscular NA Influenza subtypes A and B NA US FDA NA NA NA NA NA https://www.fda.gov/media/75156/download https://www.fda.gov/vaccines-blood-biologics/vaccines/fluvirin